Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Uwe, Nicolay"'
Publikováno v:
Vaccines, Vol 11, Iss 3, p 648 (2023)
Globally, >80 million new gonorrhea infections occur annually. Here, we assessed barriers to and influences on participation in a gonorrhea clinical trial and the impact of educational intervention. The survey was fielded in the US in March 2022. Hig
Externí odkaz:
https://doaj.org/article/9bf2259c87d34ddd87faa00c40e76527
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss , Pp S10-S17 (2019)
Objective: To assess the long-term safety of MF59-adjuvanted trivalent influenza vaccine (aIIV3; Fluad™) in adults ≥65 years of age. Methods: Data from 36 primary vaccination and 7 re-vaccination Phase I through III trials were analyzed; 7532 sub
Externí odkaz:
https://doaj.org/article/0bb66961649e408c853460ae38bf1dd0
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss , Pp S1-S9 (2019)
Objective: Compare the immunogenicity of MF59-adjuvanted trivalent inactivated influenza vaccine (aIIV3; Fluad™) versus conventional trivalent inactivated influenza vaccine (IIV3) in an integrated dataset using a meta-analysis. Methods: In a meta-a
Externí odkaz:
https://doaj.org/article/eaf77e6350a843e087c510087455d195
Publikováno v:
Vaccine. 40:2462-2469
Multiplicity issues are increasingly common in vaccine clinical studies. Common causes include multi-valent combinations/co-administrations requiring separate evaluation of each antigen; numerous efficacy endpoints; requests from regulatory authoriti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641c3c6ab04f1d746457a69d5cd80557
https://doi.org/10.1016/j.vaccine.2022.02.078
https://doi.org/10.1016/j.vaccine.2022.02.078
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss, Pp S10-S17 (2019)
Objective: To assess the long-term safety of MF59-adjuvanted trivalent influenza vaccine (aIIV3; Fluad™) in adults ≥65 years of age. Methods: Data from 36 primary vaccination and 7 re-vaccination Phase I through III trials were analyzed; 7532 sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea64f56debab255c0350cd34aabf220
https://doi.org/10.1016/j.ijid.2019.03.020
https://doi.org/10.1016/j.ijid.2019.03.020
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss, Pp S1-S9 (2019)
Objective: Compare the immunogenicity of MF59-adjuvanted trivalent inactivated influenza vaccine (aIIV3; Fluad™) versus conventional trivalent inactivated influenza vaccine (IIV3) in an integrated dataset using a meta-analysis. Methods: In a meta-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d79ff7eccc62e6d6d050caf8180772
http://www.sciencedirect.com/science/article/pii/S1201971219301559
http://www.sciencedirect.com/science/article/pii/S1201971219301559
Publikováno v:
Journal of Infectious Diseases. 213:1224-1228
Influenza vaccination strategies have targeted elderly individuals because they are at high risk of disease complications and mortality. Statins are a class of drugs used to treat hypercholesterolemia and are frequently used in the elderly population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0035589407bb995d47df2b3e17e0ad86
https://doi.org/10.1093/infdis/jiv456
https://doi.org/10.1093/infdis/jiv456
Autor:
Ashwani Kumar Arora, Vas Narasimhan, Uwe Nicolay, Nancy Nazaire Bermal, Sharon E. Frey, Eduardo Forleo-Neto, Mari Rose Aplasca-De Los Reyes, Humberto Reynales
Publikováno v:
Vaccine. 32:5027-5034
Aim Adjuvanted influenza vaccines can overcome the poor antibody response of conventional non-adjuvanted vaccines in the elderly. We evaluated the immunogenicity, safety and clinical effectiveness of an MF59®-adjuvanted trivalent influenza vaccine (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b4ca2ce24fb4e3cbec78de581f66e1
https://doi.org/10.1016/j.vaccine.2014.07.013
https://doi.org/10.1016/j.vaccine.2014.07.013
Autor:
Uwe, Nicolay1 (AUTHOR), Eva, Östblom2,3,4 (AUTHOR), Ann‐Charlotte, Egmar5 (AUTHOR), Gun, Nordström6,7 (AUTHOR), Ann, Gardulf1 (AUTHOR)
Publikováno v:
Scandinavian Journal of Caring Sciences. Dec2012, Vol. 26 Issue 4, p679-687. 9p. 6 Charts.
Autor:
Monia Bardelli, Flora Castellino, Oretta Finco, Carmine Malzone, Grazia Galli, Elena Fragapane, Francesca Buricchi, Uwe Nicolay, Barbara Capecchi, Giuseppe Del Giudice
Publikováno v:
European Journal of Immunology. 43:641-648
Cross-protection against divergent strains of influenza virus is an objective of various vaccination approaches. B cells cross-neutralizing several influenza A heterosubtypes have been isolated from cultured human memory B cells (MBCs) and plasmablas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b194fc20151bac545bdb9d455e696efb
https://doi.org/10.1002/eji.201242563
https://doi.org/10.1002/eji.201242563